ICMR recommends avoiding antibiotics for low-grade fever, issues guidelines

ICMR found in a survey that a large number of patients were no longer benefitting from the use of certain antibiotics as they have developed anti-microbial resistance to them

medicine, drugs, antibiotics
Photo: Shutterstock
BS Web Team New Delhi
2 min read Last Updated : Nov 27 2022 | 6:40 PM IST
The Indian Council of Medical Research (ICMR) on Sunday issued guidelines opposing the use of antibiotics for ailments like viral bronchitis and low-grade fever. 
 
ICMR has advised physicians to prescribe the antibiotics within a specific timeframe. It stated in its guidelines that antibiotics should be given for five days for skin and soft tissue infections, five days for pneumonia acquired in the community, and eight days for pneumonia received in a hospital.
 
The guidelines further stated, “A clinical diagnosis most often helps us predict causative pathogens fitting into a clinical syndrome which would tailor the correct antibiotic rather than blindly relying on fever, procalcitonin levels, WBC (White Blood Cell) counts, cultures or radiology to make a diagnosis of infection.”
 
It stated that only extremely ill individuals should receive empiric antibiotic therapy.
 
Empiric antibiotic therapy is typically only advised for a small subset of patients who have severe sepsis, septic shock, community-acquired pneumonia, ventilator-associated pneumonia, or necrotizing fasciitis.
 
It is crucial to start off right and then concentrate, which means determining whether empiric therapy can be justified or de-escalated before creating a strategy for the length of therapy, according to the guidelines.
 
The guidelines have been issued by ICMR after it found in a survey done between January 1 and December 31, 2021 that a large number of patients were no longer benefitting from the use of certain antibiotics as they have developed anti-microbial resistance to them.
 
Anti-microbial resistance or AMR makes illnesses difficult to cure and raises the risk of disease transmission, according to medical professionals. When bacteria, fungi, and viruses change over time and stop responding to medications, AMR happens naturally. However, according to scientists, the process can be sped up by improper use of drugs.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :ICMRAntimicrobial resistancehealth newsBS Web Reports

Next Story